Selectively Potentiating Hypoxia Levels by Combretastatin A4 Nanomedicine Toward Highly Enhanced Hypoxia-Activated Prodrug Tirapazamine Therapy for Metastatic Tumors

Selectively Potentiating Hypoxia Levels by Combretastatin A4 Nanomedicine : Toward Highly Enhanced Hypoxia-Activated Prodrug Tirapazamine Therapy for Metastatic Tumors

© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Détails bibliographiques
Publié dans:Advanced materials (Deerfield Beach, Fla.). - 1998. - 31(2019), 11 vom: 05. März, Seite e1805955
Auteur principal: Yang, Shengcai (Auteur)
Autres auteurs: Tang, Zhaohui, Hu, Chenyang, Zhang, Dawei, Shen, Na, Yu, Haiyang, Chen, Xuesi
Format: Article en ligne
Langue:English
Publié: 2019
Accès à la collection:Advanced materials (Deerfield Beach, Fla.)
Sujets:Journal Article hypoxia hypoxia-activated prodrug metastatic breast carcinoma nanomedicine vascular disrupting agent Prodrugs Stilbenes Tirapazamine 1UD32YR59G plus... fosbretabulin I5590ES2QZ
Accès en ligne Volltext